We are live on ! Find out more
PBPIA

Pivotal bioVenture Partners Investment Advisor Portfolio holdings

AUM $280M
1-Year Est. Return 181.4%
This Fund
S&P 500
This Quarter Est. Return
+77.34%
1 Year Est. Return
+181.4%
3 Year Est. Return
+730.97%
5 Year Est. Return
+1,157.4%
10 Year Est. Return
–
AUM
$394M
AUM Growth
+$143M
Cap. Flow
-$1.24M
Cap. Flow %
-0.31%
Top 10 Hldgs %
98.98%
Holding
13
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ARQT icon
Arcutis Biotherapeutics
ARQT
+$2.19M

Top Sells

Rank Stock Value
1
OCS icon
Oculis Holding
OCS
+$3.42M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$252M 63.99%
797,008
– –
PCVX icon
2
Vaxcyte
PCVX
$8.97B
$49.8M 12.63%
793,036
– –
OCS icon
3
Oculis Holding
OCS
$726M
$21.2M 5.38%
1,888,788
-329,966
-15% -$3.42M
INZY
4
DELISTED
Inozyme Pharma
INZY
$19.1M 4.86%
4,494,851
– –
FUSN
5
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$15M 3.81%
1,560,982
– –
GRCL
6
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$13.8M 3.5%
1,375,000
– –
ARQT icon
7
Arcutis Biotherapeutics
ARQT
$3.28B
$6.17M 1.57%
1,910,009
+804,700
+73% +$2.19M
RLYB icon
8
Rallybio
RLYB
$87.5M
$5.75M 1.46%
300,581
– –
EXAI
9
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$4.94M 1.25%
770,500
– –
BOLT icon
10
Bolt Biotherapeutics
BOLT
$7.32M
$2.12M 0.54%
94,573
– –
VIGL
11
DELISTED
Vigil Neuroscience
VIGL
$1.89M 0.48%
560,595
– –
IOBT
12
DELISTED
IO Biotech
IOBT
$1.62M 0.41%
864,197
– –
ALGS icon
13
Aligos Therapeutics
ALGS
$44.7M
$493K 0.13%
29,729
– –

Similar funds

HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
PHC
Panoramic Hills Capital Road Town $280M AUM
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's Q4 2023 Portfolio in Review

As of Q4 2023, Pivotal bioVenture Partners Investment Advisor held 13 positions worth $394M, up 57% from $251M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. Pivotal bioVenture Partners Investment Advisor opened no new positions and made no exits, leaving the 13-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Pivotal bioVenture Partners Investment Advisor added most to Arcutis Biotherapeutics in Q4 2023, an estimated $2.19M increase.
  • Pivotal bioVenture Partners Investment Advisor's biggest Q4 2023 reduction was Oculis Holding, cutting an estimated $3.42M.
  • Pivotal bioVenture Partners Investment Advisor's ten largest holdings make up 99% of its $394M portfolio in Q4 2023.
  • Pivotal bioVenture Partners Investment Advisor opened 0 new positions and closed 0 in Q4 2023.
  • Pivotal bioVenture Partners Investment Advisor's portfolio value rose 57% quarter-over-quarter to $394M.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q4 2023, filed 13 Feb 2024.